AstraZeneca PLC
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
5/10
|
35.25 | 117.69 | -70.05% | 63.87 | -44.8% |
| P/S |
|
4.47 | 8.16 | -45.18% |
|
|
| P/BV |
|
5.37 | 3.37 | 59.26% |
|
|
| P/FCF |
|
30 | 160.84 | -81.35% |
|
|
| Ev/Ebitda |
|
15.84 | 52.39 | -69.77% |
|
|
| Ev/S |
|
4.96 | 6.96 | -28.76% |
|
|
| Ev/FCF |
|
33.15 | 142.77 | -76.78% |
|
|
| E/P |
|
0.0283 | 1.47 | -98.07% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
31.31 | 24.93 | 25.59% | 20.86 | 50.14% |
| ROE |
|
15.23 | 12.96 | 17.54% |
|
|
| ROA |
|
5.9 | 6.09 | -3.2% |
|
|
| ROIC |
|
-0.09 | 15.56 | -100.58% |
|
|
| ROS |
|
12.69 | 12.55 | 1.11% |
|
|
| ROCE |
|
24.64 | 16.88 | 45.96% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
7/10
|
1.89 | 143.57 | -98.68% | 2.23 | -15.38% |
| Nеt Debt/Ebitda |
|
1.55 | -5.05 | -130.65% |
|
|
| Debt/Ratio |
|
0.2749 | 0.4053 | -32.18% |
|
|
| Debt/Equity |
|
1.23 | 11.8 | -89.58% |
|
|
| Debt/Net Income |
|
4.66 | 147.58 | -96.84% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
4.78/10
|
1.91 | 1.73 | 10.13% | 2.03 | -5.91% |
| Number of years of dividend growth |
|
1 | 1.07 | -6.58% |
|
|
| DSI |
|
0.7857 | 0.7807 | 0.6379% |
|
|
| Average dividend growth |
|
1.37 | -79.6 | -101.72% |
|
|
| Average percentage for 5 years |
|
2.03 | 2.81 | -27.83% |
|
|
| Average percentage for payments |
|
103.78 | 247.07 | -57.99% |
|
|
| Difference from average difference in sector |
|
0.1758 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
9/10
|
92.4 | 180.62 | -48.84% |
| Growth impulse Ebitda 5 years |
|
118.87 | 201.95 | -41.14% |
| Growth impulse Net Income 5 years |
|
346.07 | 160.03 | 116.25% |
| Growth impulse FCF 5 years |
|
1279 | 118.65 | 977.96% |
| Growth impulse EPS 5 years |
|
270.14 | 280.49 | -3.69% |
IP Score
6.24/10
